Papaverine Hydrochloride Injection, Solution
Product Images NDC 0517-4002

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Papaverine Hydrochloride (NDC 0517-4002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Regent, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adobe Systems (Papaverine HCl Injection Usp 1)

Chemical structure of Papaverine Hydrochloride shown as a structural formula drawing with methoxy groups and a hydrochloride salt indicated.*

FDA Label Image

5ee8d0b3-figure-02 (Papaverine HCl Injection Usp 2)

Label for Papaverine Hydrochloride Injection, USP, 60 mg/2 mL (30 mg/mL) intravenous solution. The label indicates package size of 25 vials of 2 mL each. Manufacturer is American Regent, Inc. Storage instructions and formulation details including edetate disodium and pH adjustments are also noted.*

FDA Label Image

4002-25 Serialization Label (Papaverine HCl Injection Usp 3)

A packaging label featuring a matrix barcode (Data Matrix) above text displaying lot number 0000, expiration date 12/2019, a GTIN barcode number 00305174002257, and a serial number 100000000020. The label is likely from a vial or container of Papaverine Hydrochloride 30 mg/mL injection, distributed by American Regent, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.